7-102605955-C-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 0P and 2B. BP4_Moderate
The ENST00000262940.12(RASA4):c.331G>A(p.Asp111Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00054 in 151,966 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00054 ( 0 hom., cov: 70)
Exomes 𝑓: 0.00024 ( 1 hom. )
Failed GnomAD Quality Control
Consequence
RASA4
ENST00000262940.12 missense
ENST00000262940.12 missense
Scores
10
9
Clinical Significance
Conservation
PhyloP100: 2.22
Genes affected
RASA4 (HGNC:23181): (RAS p21 protein activator 4) This gene encodes a member of the GAP1 family of GTPase-activating proteins that suppresses the Ras/mitogen-activated protein kinase pathway in response to Ca(2+). Stimuli that increase intracellular Ca(2+) levels result in the translocation of this protein to the plasma membrane, where it activates Ras GTPase activity. Consequently, Ras is converted from the active GTP-bound state to the inactive GDP-bound state and no longer activates downstream pathways that regulate gene expression, cell growth, and differentiation. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.13174713).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RASA4 | NM_006989.6 | c.331G>A | p.Asp111Asn | missense_variant | 5/21 | ENST00000262940.12 | NP_008920.5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RASA4 | ENST00000262940.12 | c.331G>A | p.Asp111Asn | missense_variant | 5/21 | 1 | NM_006989.6 | ENSP00000262940.8 | ||
ENSG00000205236 | ENST00000519541.1 | n.*221G>A | non_coding_transcript_exon_variant | 10/26 | 2 | ENSP00000429397.1 | ||||
ENSG00000205236 | ENST00000519541.1 | n.*221G>A | 3_prime_UTR_variant | 10/26 | 2 | ENSP00000429397.1 |
Frequencies
GnomAD3 genomes AF: 0.000533 AC: 81AN: 151848Hom.: 0 Cov.: 70
GnomAD3 genomes
AF:
AC:
81
AN:
151848
Hom.:
Cov.:
70
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.000237 AC: 345AN: 1454704Hom.: 1 Cov.: 110 AF XY: 0.000257 AC XY: 186AN XY: 723408
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
345
AN:
1454704
Hom.:
Cov.:
110
AF XY:
AC XY:
186
AN XY:
723408
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000540 AC: 82AN: 151966Hom.: 0 Cov.: 70 AF XY: 0.000484 AC XY: 36AN XY: 74310
GnomAD4 genome
AF:
AC:
82
AN:
151966
Hom.:
Cov.:
70
AF XY:
AC XY:
36
AN XY:
74310
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ESP6500AA
AF:
AC:
1
ESP6500EA
AF:
AC:
1
ExAC
AF:
AC:
39
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 22, 2021 | The c.331G>A (p.D111N) alteration is located in exon 5 (coding exon 5) of the RASA4 gene. This alteration results from a G to A substitution at nucleotide position 331, causing the aspartic acid (D) at amino acid position 111 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Uncertain
T;T;.;T;.;.
Eigen
Uncertain
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;.;D;D;D;D
M_CAP
Benign
D
MetaRNN
Benign
T;T;T;T;T;T
MetaSVM
Uncertain
T
MutationAssessor
Uncertain
M;.;M;.;.;.
MutationTaster
Benign
D;D;D;D;D;D
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D;D;D;D;D;D
REVEL
Benign
Sift
Benign
T;T;T;T;T;T
Sift4G
Uncertain
D;D;D;D;D;T
Polyphen
D;.;D;.;.;.
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at